These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 36512190)

  • 1. Clinicopathological Characteristics and Prognosis of 91 Patients with Seromucinous and Mucinous Borderline Ovarian Tumors: a Comparative Study.
    Wu B; Li J; Tao X; Wang J; Zhu G; Lu X; Chen R
    Reprod Sci; 2023 Jun; 30(6):1927-1937. PubMed ID: 36512190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fertility-sparing surgery in children and adolescents with borderline ovarian tumors: a retrospective study.
    Zhao J; Wang D; Wang R; He Y; Jia C; Pan L; Ma S; Wu M; Wang W; Cheng X; Yang J; Xiang Y
    J Ovarian Res; 2024 May; 17(1):96. PubMed ID: 38720349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Staging with Unilateral Salpingo-Oophorectomy and Expert Pathological Review Result in No Recurrences in a Series of 81 Intestinal-Type Mucinous Borderline Ovarian Tumors.
    Dewilde K; Moerman P; Leunen K; Amant F; Neven P; Vergote I
    Gynecol Obstet Invest; 2018; 83(1):65-69. PubMed ID: 28689208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of clinicopathologic and surgical factors on relapse and pregnancy in young patients (≤40 years old) with borderline ovarian tumors.
    Fang C; Zhao L; Chen X; Yu A; Xia L; Zhang P
    BMC Cancer; 2018 Nov; 18(1):1147. PubMed ID: 30463533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oncological and reproductive outcomes after fertility-sparing surgery in patients with seromucinous borderline ovarian tumor: Results of a large retrospective study.
    Wang D; Jia S; Jia C; Cao D; Yang J; Yang J; Xiang Y
    Gynecol Oncol; 2022 Jun; 165(3):446-452. PubMed ID: 35469684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progression of Cystadenoma to Mucinous Borderline Ovarian Tumor in Young Females: Case Series and Literature Review.
    Beroukhim G; Ozgediz D; Cohen PJ; Hui P; Morotti R; Schwartz PE; Yang-Hartwich ; Vash-Margita A
    J Pediatr Adolesc Gynecol; 2022 Jun; 35(3):359-367. PubMed ID: 34843973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Seromucinous and Mucinous Borderline Ovarian Tumors: We Need to Know More.
    Laban M; Chen X; Guo B
    Reprod Sci; 2023 May; 30(5):1684-1685. PubMed ID: 36474132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serous and mucinous borderline ovarian tumours: differences in clinical presentation, high-risk histopathological features, and lethal recurrence rates.
    Vasconcelos I; Darb-Esfahani S; Sehouli J
    BJOG; 2016 Mar; 123(4):498-508. PubMed ID: 26705090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of appendectomy in patients with mucinous borderline ovarian tumors.
    Song T; Kim MK; Jung YW; Yun BS; Seong SJ; Choi CH; Kim TJ; Lee JW; Kim BG; Bae DS
    Eur J Obstet Gynecol Reprod Biol; 2018 Oct; 229():112-116. PubMed ID: 30145525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathologic Features and Risk Factors for Recurrence of Mucinous Borderline Ovarian Tumors: A Retrospective Study With Follow-up of More Than 10 Years.
    Sun L; Li N; Song Y; Wang G; Zhao Z; Wu L
    Int J Gynecol Cancer; 2018 Nov; 28(9):1643-1649. PubMed ID: 30365456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mucinous borderline ovarian tumors with and without Intraepithelial Carcinoma: Differences in clinicopathologic features and fertility results.
    Chen RF; Tao X; Wu BB; Li J; Wang JY; Gu WY; Lu X
    J Obstet Gynaecol Res; 2020 Apr; 46(4):646-653. PubMed ID: 32045956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Impact of Surgical Staging on the Prognosis of Mucinous Borderline Tumors of the Ovaries: A Multicenter Study.
    Gungorduk K; Asicioglu O; Braicu EI; Almuheimid J; Gokulu SG; Cetinkaya N; Gungor T; Pakay G; Telli EU; Cuylan ZF; Toptas T; Bilgi A; Ozyurt R; Agacayak E; Ozdemir A; Yildirim N; Taskin S; Oge T; Erol O; Akman L; Turan A; Icen MS; Senol T; Ovali OI; Yucesoy B; Gungorduk O; Temizkan O; Sanci M; Simsek T; Meydanli MM; Harma M; Yasar L; Uysal AD; Karateke A; Ortac F; Ozalp SS; Sehouli J; Muallem MZ
    Anticancer Res; 2017 Oct; 37(10):5609-5616. PubMed ID: 28982877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors associated with misdiagnosis of frozen section of mucinous borderline ovarian tumor.
    Zhang W; Jia S; Xiang Y; Yang J; Jia C; Leng J
    J Int Med Res; 2019 Jan; 47(1):96-104. PubMed ID: 30198356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mucinous borderline ovarian tumors: Analysis of 75 patients from a single center.
    Cömert DK; Üreyen I; Karalok A; Taşçı T; Türkmen O; Öcalan R; Turan T; Tulunay G
    J Turk Ger Gynecol Assoc; 2016; 17(2):96-100. PubMed ID: 27403076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ovarian Seromucinous Borderline Tumors Are Histologically Different from Mucinous Borderline Tumors.
    Hada T; Miyamoto M; Ishibashi H; Kawauchi H; Soyama H; Matsuura H; Sakamoto T; Kakimoto S; Aoyama T; Iwahashi H; Suzuki R; Tsuda H; Takano M
    In Vivo; 2020; 34(3):1341-1346. PubMed ID: 32354928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The clinicopathological features and risk factors of recurrence in patients with mucinous borderline ovarian tumors].
    Sun L; Song Y; Li N; Yuan GW; Sun YC; Li N; Ma SK; Zhang X; Wu LY
    Zhonghua Zhong Liu Za Zhi; 2017 Aug; 39(8):589-594. PubMed ID: 28835081
    [No Abstract]   [Full Text] [Related]  

  • 17. Performing Routine Appendectomy in Mucinous Borderline Ovarian Tumours: An Experience of 15 Years From a Cancer Centre.
    Habib M; Azam Khalil K; Tayyab Z; Saeed Usmani A; Ahmed Y; Shah A; Ali Syed A
    Cureus; 2024 Jul; 16(7):e65580. PubMed ID: 39192897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oncological outcomes and risk factors for recurrence of mucinous borderline ovarian tumors: A 15-year experience at a tertiary center.
    Poonyakanok V; Warnnissorn M; Chaopotong P
    J Obstet Gynaecol Res; 2024 Nov; 50(11):2081-2092. PubMed ID: 39323179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retrospective study of characteristics and hyperthermia intraperitoneal perfusion in mucinous borderline ovarian tumor and mucinous ovarian carcinoma.
    He X; Ying R; Jia L; Li Y; Li R
    Gland Surg; 2023 Apr; 12(4):453-464. PubMed ID: 37200926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ovarian seromucinous carcinoma: an independent epithelial ovarian cancer?
    Hu Y; Fu K; Liu H; He Q; Qiu X; Yang W; Zhang Y
    J Ovarian Res; 2023 Jan; 16(1):18. PubMed ID: 36670456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.